Providing Market Intelligence for 40 Years

In The News

Gaming Consoles Still Top OTT Video Conduit

Of the platforms, Roku, which just launched a 4K-capable model, is now the third-most commonly used connected CE device for video streaming (10%), behind Microsoft’s Xbox (14%) and Sony’s PlayStation consoles (13%), Parks Associates said, noting that usage declined for both connected gaming consoles and DVRs, paired with a modest increase for smart TVs (see chart).

“Streaming media players continue to stake out a growing portion of the connected home,” said Barbara Kraus, director of research at Parks Associates, in a statement about the report -- The Streaming Media Device Landscape. “It is a rapid ascendance for streaming media players, and Roku in particular, especially considering the broad base of gaming console ownership compared to the lower penetration of streaming media devices.”

From the article "Gaming Consoles Still Top OTT Video Conduit" by Jeff Baumgartner.

Previously In The News

One in five US subscribers now ‘dissatisfied’ with pay TV service

Some 20% of US pay TV subscribers are now dissatisfied with their pay TV service, according to research from Parks Associates. The future represents a 100% increase since 2013, according to Parks....

OTT churn increases in US during pandemic

According to Parks Associates, an increasing number of US broadband households cancelled at least one OTT subscription in the early part of the year, with a significant number also utilising the free...

Over Two-Thirds Of U.S. Smartphone Owners Stream Music Daily

A recent Parks Associates report reveals that 68 percent of U.S. smartphone owners listen to streaming music every day, for an average of 45 minutes per day. Amazon Prime Music emerged as the most pop...

Morning Read: Pharma Changes Afoot As Valeant Courts A New CEO And Novartis U.S. Head Exits

Less than half of caregivers with a smartphone use apps aimed at caregivers, according to a report by Parks Associates. — MobiHealthNews From the article "Morning Read: Pharma Changes Afoot As Vale...